Difference between revisions of "Other CNS embryonal tumours"

From Libre Pathology
Jump to navigation Jump to search
(→‎General: +ihc)
Line 46: Line 46:
** BCOR-positive IHC: ''HGNET BCOR‐altered neuroepithelial tumours''
** BCOR-positive IHC: ''HGNET BCOR‐altered neuroepithelial tumours''


==IHC==
CNS Ganglioneuroblastoma + Neuroblastoma
* Syn -/+ve.
* Vim -ve.
* GFAP usu -ve.
* MIB-1 usu high.


Medulloepthelioma


DDx:
DDx:
Line 53: Line 60:
* [[Anaplastic ependymoma]]
* [[Anaplastic ependymoma]]
* H3F3A G34-mutated [[Glioblastoma]]
* H3F3A G34-mutated [[Glioblastoma]]
[[Category:Neuropathology]]

Revision as of 12:32, 1 April 2019

Other CNS embryonal tumours
Diagnosis in short

Other CNS embryonal tumorH&E stain.

Synonyms CNS-PNET
LM DDx small round blue cell tumours
IHC S-100 +ve, Syn +/-ve
Site brain, spinal cord

Prevalence rare - typically in children and young adults
Prognosis poor (WHO Grade IV)


Other CNS embryonal tumor, was introduced in the WHO 2016 classification of CNS tumors. Some of these tumors of this category has been previously designated as CNS-PNET but this terminology has been abandoned.

General

Other CNS embryonal tumours are a group of primitive neuroeptithelial tumors that are to be classified in distinct molecular groups in the future. Currently it is a exlcusion criteria encompassing four subgroups

  • CNS neuroblastomas
  • CNS ganglioneuroblastomas.
    • often characterized by FOXR2 fusions: CNS neuroblastoma with FOXR2 activation (NB‐FOXR2)
  • CNS medulloepithelioma.
    • but absence of C19MC alteration, otherwise classified as ETMR
  • CNS embryonal tumour, NOS
    • Similarities to astroblastoma: High‐grade neuroepithelial tumours with MN1 alteration (HGNET‐MN1)
    • NUTM1-positive IHC: Ewing's sarcoma family tumour with CIC alteration (EFT‐CIC)
    • BCOR-positive IHC: HGNET BCOR‐altered neuroepithelial tumours

IHC

CNS Ganglioneuroblastoma + Neuroblastoma

  • Syn -/+ve.
  • Vim -ve.
  • GFAP usu -ve.
  • MIB-1 usu high.

Medulloepthelioma

DDx: